PEN Penumbra Inc

Price (delayed)

$267.75

Market cap

$9.79B

P/E Ratio

622.67

Dividend/share

N/A

EPS

$0.43

Enterprise value

$9.84B

Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses ...

Highlights
The net income has increased by 49% YoY
PEN's EPS is up by 43% YoY
Penumbra's quick ratio has decreased by 28% YoY but it has increased by 5% QoQ
Penumbra's debt has surged by 68% QoQ and by 66% YoY
Penumbra's gross margin has decreased by 6% YoY

Key stats

What are the main financial stats of PEN
Market
Shares outstanding
36.58M
Market cap
$9.79B
Enterprise value
$9.84B
Valuations
Price to earnings (P/E)
622.67
Price to book (P/B)
14.39
Price to sales (P/S)
14.56
EV/EBIT
1,550.52
EV/EBITDA
487.91
EV/Sales
14.66
Earnings
Revenue
$671.44M
EBIT
$6.35M
EBITDA
$20.17M
Free cash flow
-$38.5M
Per share
EPS
$0.43
Free cash flow per share
-$1.05
Book value per share
$18.61
Revenue per share
$18.38
TBVPS
$24.43
Balance sheet
Total assets
$910.22M
Total liabilities
$236.84M
Debt
$128.97M
Equity
$678.93M
Working capital
$545.07M
Liquidity
Debt to equity
0.19
Current ratio
6.04
Quick ratio
3.48
Net debt/EBITDA
2.31
Margins
EBITDA margin
3%
Gross margin
61.8%
Net margin
2.4%
Operating margin
0.3%
Efficiency
Return on assets
1.9%
Return on equity
2.4%
Return on invested capital
0.9%
Return on capital employed
0.8%
Return on sales
0.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

PEN stock price

How has the Penumbra stock price performed over time
Intraday
-0.73%
1 week
4.91%
1 month
-7.31%
1 year
24.3%
YTD
53%
QTD
0.47%

Financial performance

How have Penumbra's revenue and profit performed over time
Revenue
$671.44M
Gross profit
$415.26M
Operating income
$1.87M
Net income
$15.9M
Gross margin
61.8%
Net margin
2.4%
PEN's operating margin has soared by 107% from the previous quarter but it has plunged by 75% YoY
Penumbra's operating income has surged by 107% QoQ but it has shrunk by 71% YoY
The net income has increased by 49% YoY
PEN's revenue is up by 27% year-on-year and by 13% since the previous quarter

Growth

What is Penumbra's growth rate over time

Valuation

What is Penumbra stock price valuation
P/E
622.67
P/B
14.39
P/S
14.56
EV/EBIT
1,550.52
EV/EBITDA
487.91
EV/Sales
14.66
PEN's EPS is up by 43% YoY
The stock's P/B is 37% above its 5-year quarterly average of 10.5 and 13% above its last 4 quarters average of 12.7
PEN's equity is up by 9% year-on-year and by 3.6% since the previous quarter
PEN's price to sales (P/S) is 32% higher than its 5-year quarterly average of 11.0 and 4.7% higher than its last 4 quarters average of 13.9
PEN's revenue is up by 27% year-on-year and by 13% since the previous quarter

Efficiency

How efficient is Penumbra business performance
The company's return on invested capital has surged by 130% QoQ but it fell by 47% YoY
PEN's ROS has soared by 126% QoQ but it has shrunk by 50% YoY
The ROA has grown by 19% YoY
The ROE has grown by 14% YoY

Dividends

What is PEN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PEN.

Financial health

How did Penumbra financials performed over time
PEN's total liabilities has soared by 51% YoY and by 24% from the previous quarter
Penumbra's quick ratio has decreased by 28% YoY but it has increased by 5% QoQ
Penumbra's debt is 81% lower than its equity
Penumbra's debt has surged by 68% QoQ and by 66% YoY
PEN's debt to equity has surged by 58% since the previous quarter and by 58% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.